Oscar Health Statistics
Total Valuation
Oscar Health has a market cap or net worth of $3.86 billion. The enterprise value is $1.61 billion.
Important Dates
The last earnings date was Wednesday, August 6, 2025, before market open.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Oscar Health has 258.24 million shares outstanding. The number of shares has decreased by -4.81% in one year.
Current Share Class | 222.73M |
Shares Outstanding | 258.24M |
Shares Change (YoY) | -4.81% |
Shares Change (QoQ) | -16.48% |
Owned by Insiders (%) | 3.39% |
Owned by Institutions (%) | 69.84% |
Float | 210.30M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.35 |
Forward PS | 0.32 |
PB Ratio | 3.33 |
P/TBV Ratio | 3.33 |
P/FCF Ratio | 3.21 |
P/OCF Ratio | 3.12 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.15 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 1.34 |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.31.
Current Ratio | 0.89 |
Quick Ratio | 0.84 |
Debt / Equity | 0.31 |
Debt / EBITDA | n/a |
Debt / FCF | 0.30 |
Interest Coverage | -5.47 |
Financial Efficiency
Return on equity (ROE) is -13.96% and return on invested capital (ROIC) is -5.35%.
Return on Equity (ROE) | -13.96% |
Return on Assets (ROA) | -1.42% |
Return on Invested Capital (ROIC) | -5.35% |
Return on Capital Employed (ROCE) | -8.53% |
Revenue Per Employee | $4.47M |
Profits Per Employee | -$67,180 |
Employee Count | 2,400 |
Asset Turnover | 1.88 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Oscar Health has paid $9.33 million in taxes.
Income Tax | 9.33M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.96% in the last 52 weeks. The beta is 1.86, so Oscar Health's price volatility has been higher than the market average.
Beta (5Y) | 1.86 |
52-Week Price Change | -16.96% |
50-Day Moving Average | 15.82 |
200-Day Moving Average | 15.03 |
Relative Strength Index (RSI) | 49.47 |
Average Volume (20 Days) | 30,865,689 |
Short Selling Information
The latest short interest is 60.08 million, so 23.27% of the outstanding shares have been sold short.
Short Interest | 60.08M |
Short Previous Month | 28.59M |
Short % of Shares Out | 23.27% |
Short % of Float | 28.57% |
Short Ratio (days to cover) | 1.57 |
Income Statement
In the last 12 months, Oscar Health had revenue of $10.73 billion and -$161.23 million in losses. Loss per share was -$0.69.
Revenue | 10.73B |
Gross Profit | 1.84B |
Operating Income | -129.47M |
Pretax Income | 23.89M |
Net Income | -161.23M |
EBITDA | -99.03M |
EBIT | -129.47M |
Loss Per Share | -$0.69 |
Full Income Statement Balance Sheet
The company has $3.54 billion in cash and $357.22 million in debt, giving a net cash position of $2.24 billion or $8.68 per share.
Cash & Cash Equivalents | 3.54B |
Total Debt | 357.22M |
Net Cash | 2.24B |
Net Cash Per Share | $8.68 |
Equity (Book Value) | 1.16B |
Book Value Per Share | 4.49 |
Working Capital | -552.34M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $1.23 billion and capital expenditures -$32.69 million, giving a free cash flow of $1.20 billion.
Operating Cash Flow | 1.23B |
Capital Expenditures | -32.69M |
Free Cash Flow | 1.20B |
FCF Per Share | $4.65 |
Full Cash Flow Statement Margins
Gross margin is 17.20%, with operating and profit margins of -1.21% and -1.50%.
Gross Margin | 17.20% |
Operating Margin | -1.21% |
Pretax Margin | -1.41% |
Profit Margin | -1.50% |
EBITDA Margin | -0.92% |
EBIT Margin | -1.21% |
FCF Margin | 11.20% |
Dividends & Yields
Oscar Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 4.81% |
Shareholder Yield | 4.81% |
Earnings Yield | -4.18% |
FCF Yield | 31.17% |
Dividend Details Analyst Forecast
The average price target for Oscar Health is $12.79, which is -14.33% lower than the current price. The consensus rating is "Sell".
Price Target | $12.79 |
Price Target Difference | -14.33% |
Analyst Consensus | Sell |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |